Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €4.96 EUR
Change Today -0.081 / -1.61%
Volume 78.3K
THR On Other Exchanges
Symbol
Exchange
EN Brussels
As of 11:35 AM 08/3/15 All times are local (Market data is delayed by at least 15 minutes).

Insiders at thrombogenics nv (THR)

Name (Connections)Board RelationshipsTitleType of Board MemberAge
Patrik De Haes ViBio, BVBA8 RelationshipsChief Executive Officer and Executive DirectorChief Executive Officer--
Luc Philips BVBA31 RelationshipsExecutive Director and Member of Audit CommitteeSenior Key Executive64
Paul Howes 97 RelationshipsExecutive DirectorSenior Key Executive61

Other Board Members on Board*

Name (Connections)Board RelationshipsType of Board MemberPrimary CompanyAge
Gustaaf Van Reet Ph.D. 41 RelationshipsChairman of the BoardThromboGenics NV70
Thomas Clay 12 RelationshipsMember of the Board of DirectorsEast Hill Management Company, LLC30
Patricia Ceysens 8 RelationshipsMember of the Board of DirectorsThromboGenics NV--
David Guyer M.D. 48 RelationshipsMember of the Board of DirectorsOphthotech Corporation55
Emmanuele Attout 8 RelationshipsMember of the Board of DirectorsThromboGenics NV--
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
THR:BB €4.96 EUR -0.081

THR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for THR.
View Industry Companies
 

Industry Analysis

THR

Industry Average

Valuation THR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.0x
Price/Book 0.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact THROMBOGENICS NV, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.